CompletedPhase 4NCT01593722
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
Studying Loiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Amy D Klion, M.D.National Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- Diethylcarbamazine(drug)
- Enrollment
- 155 enrolled
- Eligibility
- 20-60 years · All sexes
- Timeline
- 2012 – 2014
Study locations (1)
- Filariasis and other Tropical Diseases Research Center, Yaoundé, Cameroon
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01593722 on ClinicalTrials.govOther trials for Loiasis
Additional recruiting or active studies for the same condition.